Formidable Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65K	Buy	10,600 +500	+5%	+$3.65K	0.01%	376
2025 Q4	$186K	Sell	10,100 -200	-2%	-$2.16K	0.03%	388
2025 Q3	$134K	Sell	10,300 -4,400	-30%	-$70.7K	0.02%	380
2025 Q2	$156K	Hold	14,700	–	–	0.03%	372
2025 Q1	$156K	Sell	14,700 -3,500	-19%	-$55.6K	0.03%	373
2024 Q4	$309K	Sell	18,200 -100	-0.5%	-$1.88K	0.05%	296
2024 Q3	$425K	Sell	18,300 -500	-3%	-$10.7K	0.07%	247
2024 Q2	$458K	Buy	18,800 +900	+5%	+$27.3K	0.07%	245
2024 Q1	$604K	Buy	17,900 +2,350	+15%	+$83.3K	0.1%	211
2023 Q4	$490K	Buy	15,550 +500	+3%	+$11.9K	0.1%	173
2023 Q3	$385K	Buy	15,050 +100	+0.7%	+$3.08K	0.09%	201
2023 Q2	$429K	Hold	14,950	–	–	0.09%	185
2023 Q1	$384K	Sell	14,950 -900	-6%	-$16.1K	0.08%	200
2022 Q4	$269K	Buy	15,850 +200	+1%	+$3.49K	0.06%	241
2022 Q3	$261K	Buy	15,650 +700	+5%	+$11.7K	0.06%	234
2022 Q2	$235K	Buy	14,950 +900	+6%	+$17.7K	0.05%	254
2022 Q1	$379K	Buy	14,050 +1,100	+8%	+$28.1K	0.07%	224
2021 Q4	$498K	Sell	12,950 -300	-2%	-$12.2K	0.1%	188
2021 Q3	$633K	Buy	13,250 +925	+8%	+$41.5K	0.12%	166
2021 Q2	$346K	Buy	12,325 +5,450	+79%	+$184K	0.07%	207
2021 Q1	$278K	Buy	+6,875	New	+$410K	0.06%	223
2020 Q3	–	Sell	-4,866	Closed	-$263K	–	267
2020 Q2	$263K	Buy	+4,866	New	+$168K	0.08%	194
2017 Q4	–	Sell	-1,919	Closed	-$14K	–	117
2017 Q3	$14K	Buy	+1,919	New	+$14.5K	0.01%	199
2017 Q1	–	Sell	-1,969	Closed	-$29K	–	204
2016 Q4	$29K	Sell	1,969 -329	-14%	-$4.92K	0.01%	169
2016 Q3	$40K	Buy	2,298 +229	+11%	+$7.4K	0.02%	166
2016 Q2	$61K	Buy	+2,069	New	+$65.2K	0.03%	157